Live Breaking News & Updates on Pooled analysis

Stay informed with the latest breaking news from Pooled analysis on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Pooled analysis and stay connected to the pulse of your community

Verona Pharma to Present Additional Analyses of Positive Phase 3 ENHANCE Studies in COPD at ATS 2024

PDUFA Target Action Date of June 26, 2024 Eight posters including two oral presentations support potential of ensifentrine,an investigational, first-in-class, selective, dual inhibitor of PDE3 and...

United-states , Texas , London , City-of , United-kingdom , Manchester , Alabama , Claremont , Surrey , American , Frank-sciurba , Mark-dransfield

Verona Pharma To Present Additional Analyses Of Positive Phase 3 ENHANCE Studies In COPD At ATS 2024

Verona Pharma To Present Additional Analyses Of Positive Phase 3 ENHANCE Studies In COPD At ATS 2024
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United-states , Manchester , United-kingdom , Claremont , Surrey , Alabama , London , City-of , Texas , American , Donald-mahler , Ravi-kalhan

AMGEN HIGHLIGHTS NEW COPD, ASTHMA AND VASCULITIS RESEARCH AT ATS 2024

/PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the presentation of new respiratory data at the American Thoracic Society (ATS) 2024 International...

United-states , San-diego , California , Puerto-rico , American , America , Kate-meyer , Jessica-akopyan , Justin-claeys , Lymphopoietin-isoforms , Jay-bradner , World-most-innovative-companies

A Pooled Analysis of Trastuzumab Deruxtecan in Patients With HER2- Positive Metastatic Breast Cancer With Brain Metastases (BMs) from DESTINY-Breast01, -02, and -03

Sara Tolaney, MD, MPH, presents an exploratory pooled analysis of efficacy and safety data of trastuzumab deruxtecan vs comparator in patients with HER2-positive metastatic breast cancer and brain metastases from DESTINY-Breast01, -02, and -03.

Trastuzumab-deruxtecan , Pooled-analysis , Patients-with , Metastatic-breast-cancer-with-brain-metastases , Breast-cancer , Sara-tolaney , D , Ph , Rapid-readout ,

Obecabtagene Autoleucel (obe-cel, AUTO1) for Relapsed/Refractory Adult B-Cell Acute Lymphoblastic Leukemia (R/R B-ALL): Pooled Analysis of the Ongoing FELIX Phase Ib/II Study

Claire Roddie, MD, PhD, presents data from the pooled analysis of the ongoing FELIX phase Ib/II study investigating obecabtagene autoleucel in patients with relapsed/refractory adult B-cell acute lymphoblastic leukemia.

San-diego , California , United-states , Philadelphia , Pennsylvania , Obecabtagene-autoleucel , Claire-roddie , Pooled-analysis , Clin-oncol , Median-dor , Felix-study

Autolus Therapeutics (AUTL) Presents Clinical Data Updates

Autolus Therapeutics (AUTL) Presents Clinical Data Updates
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-kingdom , United-states , San-diego , California , San-diego-convention-center , American , Lydia-lee , Obecabtagene-autoleucel , Julia-wilson , Susana-noonan , Claire-roddie , Lauren-williams

Autolus Therapeutics Presents Clinical Data Updates at the

Autolus Therapeutics Presents Clinical Data Updates at the
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

San-diego , California , United-states , San-diego-convention-center , United-kingdom , London , City-of , American , Susana-noonan , Claire-roddie , Lauren-williams , Lydia-lee

Autolus Therapeutics Presents Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2023

Pooled analysis of the FELIX Phase Ib/II study demonstrated prolonged event free survival and low overall immunotoxicity across all cohorts in r/r B-ALL, and particularly in patients with low leukemic...

London , City-of , United-kingdom , San-diego , California , United-states , San-diego-convention-center , American , Julia-wilson , Lauren-williams , Lydia-lee , Obecabtagene-autoleucel

Pooled Analysis Supports Bioequivalence Between MB02 and Reference Bevacizumab

In a new pooled analysis of 3 pharmacokinetic studies, the investigators confirmed the bioequivalence, safety, and immunogenicity between biosimilar MB02 and European Union approved bevacizumab and US-approved bevacizumab.

Spain , Japan , Madrid , United-states , Japanese , Abxience-research , European-union , New-england-journal , Body-mass-index , Medical-department , European-union-approved